Who invested in Axsome Therapeutics?
Axsome Therapeutics's investors include Blackstone Group and Hercules Capital.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$577Mraised across 5 rounds since 2013, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $2.5M sold, first sale May 2015
No investor was named in the report.
From a historical funding recordSEC filing: $1.3M sold, first sale Dec 2014
No investor was named in the report.
From a historical funding recordSEC filing: $2.0M sold, first sale Sept 2014
No investor was named in the report.
Reported by sec.govSEC filing: $1.2M sold, first sale Jun 2013
From the SEC filings it signed: 1 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Axsome Therapeutics's investors include Blackstone Group and Hercules Capital.
Axsome Therapeutics has raised $577M across 5 rounds since 2013.
Axsome Therapeutics's most recent round was a Debt of $570M in May 2025.
Its most recent round, $570M in May 2025, is also its largest on record.
Axsome Therapeutics's first round on record, in May 2025, was backed by Blackstone Group and Hercules Capital.
Axsome Therapeutics's latest named round is a Debt, in May 2025.
Axsome Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.